Key result
In 81 hemodialysis patients followed for 20 months, increased serum cTnT was not associated with an increase in mortality (16.3% vs 18.4% in those with normal cTnT).
Absolute Event Rate: 16.3% vs 18.4%
No takes yet. Share an insight, caveat, or question.
Should not yet inform cTnT-based risk stratification in hemodialysis; leaves open its prognostic value in larger studies.
McNeil et al. (1998) conducted a letter in End-stage renal disease (hemodialysis) (n=81). Increased serum cTnT (>0.1 μg/L) vs. cTnT within reference values was evaluated on Mortality. In 81 hemodialysis patients followed for 20 months, increased serum cTnT was not associated with an increase in mortality (16.3% vs 18.4% in those with normal cTnT).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: